These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Transcatheter Aortic Valve Replacement: The Good Results of the New Generation of Transcatheter Aortic Valve Replacement Devices Are Confirmed. Vahanian A; Himbert D JACC Cardiovasc Interv; 2016 Feb; 9(4):385-386. PubMed ID: 26892085 [No Abstract] [Full Text] [Related]
65. Rapid-Deployment Aortic Valves in a Small Aortic Root: Prosthesis-Patient Mismatch and Pacemaker Implantation: Reply. Coti I; Laufer G; Andreas M Ann Thorac Surg; 2021 Jan; 111(1):379-380. PubMed ID: 32511995 [No Abstract] [Full Text] [Related]
66. Predictors of permanent pacemaker insertion after TAVR: A systematic review and updated meta-analysis. Mahajan S; Gupta R; Malik AH; Mahajan P; Aedma SK; Aronow WS; Mehta SS; Lakkireddy DR J Cardiovasc Electrophysiol; 2021 May; 32(5):1411-1420. PubMed ID: 33682218 [TBL] [Abstract][Full Text] [Related]
74. [Transcatheter aortic valve implantation and conduction disturbances]. Ait Said M; Coquard C; Horvilleur J; Manenti V; Fiorina L; Lacotte J; Salerno F Ann Cardiol Angeiol (Paris); 2019 Dec; 68(6):443-449. PubMed ID: 31668339 [TBL] [Abstract][Full Text] [Related]
75. Reply to the Editor-Effect of permanent pacemakers on survival after transcatheter aortic valve replacement. Hochstadt A Heart Rhythm; 2021 Feb; 18(2):332-333. PubMed ID: 33207249 [No Abstract] [Full Text] [Related]
76. Outcomes with a latest generation self-expandable, intra-annular, re-sheathable transcatheter heart valve system: analysis of patients with impaired left ventricular function and determinants for pacemaker implantation. Schaefer A; Neumann N; Linder M; Schofer N; Schneeberger Y; Deuschl F; Schoen G; Blankenberg S; Reichenspurner H; Conradi L; Schäfer U Clin Res Cardiol; 2018 Oct; 107(10):914-923. PubMed ID: 29705866 [TBL] [Abstract][Full Text] [Related]
77. Computed tomography (CT) assessment of the membranous septal anatomy prior to transcatheter aortic valve replacement (TAVR) with the balloon-expandable SAPIEN 3 valve. Oestreich BA; Mbai M; Gurevich S; Nijjar PS; Adabag S; Bertog S; Kelly R; Garcia S Cardiovasc Revasc Med; 2018; 19(5 Pt B):626-631. PubMed ID: 29352699 [TBL] [Abstract][Full Text] [Related]
78. Balloon-expandable versus self-expanding transcatheter aortic valve replacement for bioprosthetic dysfunction: A systematic review and meta-analysis. Lee HA; Chou AH; Wu VC; Chen DY; Lee HF; Lee KT; Chu PH; Cheng YT; Chang SH; Chen SW PLoS One; 2020; 15(6):e0233894. PubMed ID: 32479546 [TBL] [Abstract][Full Text] [Related]
79. Timing of Onset and Outcome of New Conduction Abnormalities Following Transcatheter Aortic Valve Implantation: Role of Balloon Aortic Valvuloplasty. Campelo-Parada F; Nombela-Franco L; Urena M; Regueiro A; Jiménez-Quevedo P; Del Trigo M; Chamandi C; Rodríguez-Gabella T; Auffret V; Abdul-Jawad Altisent O; DeLarochellière R; Paradis JM; Dumont E; Philippon F; Pérez-Castellano N; Puri R; Macaya C; Rodés-Cabau J Rev Esp Cardiol (Engl Ed); 2018 Mar; 71(3):162-169. PubMed ID: 28566243 [TBL] [Abstract][Full Text] [Related]
80. Who needs a permanent pacemaker after transcatheter aortic valve implantation? Bacik P; Poliacikova P; Kaliska G Bratisl Lek Listy; 2018; 119(9):560-565. PubMed ID: 30226066 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]